Cited by 69Cancer survivorship and careCancer-related cognitive impairment studiesLong-Term Effects of COVID-19

A Systematic Review of the Safety and Effect of Neurofeedback on Fatigue and Cognition

Open access
Luctkar-Flude, Marian, Groll, Dianne·2015·Integrative Cancer Therapies

Abstract

Background. Many cancer survivors continue to experience ongoing symptoms, such as fatigue and cognitive impairment, which are poorly managed and have few effective, evidence-based treatment options. Neurofeedback is a noninvasive, drug-free form of brain training that may alleviate long-term symptoms reported by cancer patients. Objective. The purpose of this systematic review of the literature was to describe the effectiveness and safety of neurofeedback for managing fatigue and cognitive impairment. Methods. A systematic review of the literature was conducted using Joanna Briggs Institute (JBI) methodology. A comprehensive search of 5 databases was conducted: Medline, CINAHL, AMED, PsycInfo, and Embase. Randomized and nonrandomized controlled trials, controlled before and after studies, cohort, case control studies, and descriptive studies were included in this review. Results. Twenty-seven relevant studies were included in the critical appraisals. The quality of most studies was poor to moderate based on the JBI critical appraisal checklists. Seventeen studies were deemed of sufficient quality to be included in the review: 10 experimental studies and 7 descriptive studies. Of these, only 2 were rated as high-quality studies and the remaining were rated as moderate quality. All 17 included studies reported positive results for at least one fatigue or cognitive outcome in a variety of populations, including 1 study with breast cancer survivors. Neurofeedback interventions were well tolerated with only 3 studies reporting any side effects. Conclusions. Despite issues with methodological quality, the overall positive findings and few reported side effects suggest neurofeedback could be helpful in alleviating fatigue and cognitive impairment. Currently, there is insufficient evidence that neurofeedback is an effective therapy for management of these symptoms in cancer survivors, however, these promising results support the need for further research with this patient population. More information about which neurofeedback technologies, approaches, and protocols could be successfully used with cancer survivors and with minimal side effects is needed. This research will have significance to nurses and physicians in oncology and primary care settings who provide follow-up care and counseling to cancer survivors experiencing debilitating symptoms in order to provide information and education related to evidence-based therapy options.

Integrity signals

Registry

Crossref · 10.1177/1534735415572886

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 58 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Luctkar-Flude, M., & Groll, D.
Affiliations
  • Queen’s University, Kingston, Ontario, Canada
  • Queen's University (CA)
Venue
Integrative Cancer Therapies
Published
2015-02-25
Volume
14
Issue
4
Pages
318-340
ISSN
  • 1534-7354 (ISSN-L)
  • 1552-695X
OpenAlex
W2156824866
Cited by
69
References
58
Citations by year
2026: 5 · 2025: 7 · 2024: 12 · 2023: 8 · 2022: 10 · 2021: 6 · 2020: 4 · 2019: 7 · 2018: 5 · 2017: 4 · 2016: 1
FWCI
0.36
Type
journal article
Language
en
Open access
Locations
  • Integrative Cancer Therapies (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
Keywords
neurofeedback, cancer survivors, cancer-related fatigue, cognitive impairment, treatment safety, adverse effects, brain training, breast cancer survivors, symptom management
MeSH terms
Cognition Disorders, Fatigue, Humans, Neoplasms, Treatment Outcome, Survivors, Neurofeedback

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review